Upload
mohammed-sarhan
View
233
Download
0
Embed Size (px)
Citation preview
7/31/2019 Conference Ayman
1/21
7/31/2019 Conference Ayman
2/21
7/31/2019 Conference Ayman
3/21
Schistosomiasis is the third most devastatingtropical disease in the world, being a majorsource of morbidity and mortality for developing
countries.
The pathogenesis of schistosomiasis is mainly
due to thehosts
immune response againstSchistosoma eggs trapped in tissues leading togranuloma formation.
In late cases, hepatic fibrosis may lead to end-stage liver failure.
7/31/2019 Conference Ayman
4/21
Although many hopes rely upon livertransplantation as a treatment, thereare limited available donor livers for
the hundred millions of patients
worldwide.
Thus, it is very important toinvestigate new therapies.
7/31/2019 Conference Ayman
5/21
MSCs show great plasticity &can differentiate into differentbody cells includinghepatocytes. MSCs can replace
diseased or dysfunctioningcells with healthy functioningones.
For these reasons, the MSCsare currently being tested fortheir potential use in celltransplantation therapy for a
number of diseases.
However, this concept needs to beextensively investigated beforeclinical trials on human cases.
7/31/2019 Conference Ayman
6/21
Murine schistosomiasis model of hepatic
fibrosis represents an experimental modelof liver collagen deposition, the course ofwhich resembles that of the humandisease.
Thus, trials on the impact of MSCs therapyon murine model are very essential from
both the scientific and ethical points ofview before clinical trials on human cases.
7/31/2019 Conference Ayman
7/21
7/31/2019 Conference Ayman
8/21
1- Infection of Swiss albino female mice withSchistosomamansoni
2- Separation of BM-MSCs from male mice andcell culture:
(x200)
7/31/2019 Conference Ayman
9/21
3- MSCs administration into the liver(in situ) of the test group at 10 weeks
post infection (500,000 cells/ mouse)
4- Mice scarification at 4 weeks post
administration
5- Histopathological examination &
morphometric analysis of liver slidesstained with H&E or Masson trichrome(to assess fibrosis)
7/31/2019 Conference Ayman
10/21
7- Electron microscopy of liver slides to
detect newly formed hepatocytes
6- Immunno-histochemical examinationof liver sections to detect -SMA
8- PCR detection of male-derived MSCs
9- Statistical analysis
7/31/2019 Conference Ayman
11/21
7/31/2019 Conference Ayman
12/21
Histopathological examination &morphmetric analysis of liver slides stained
with H&E
H&E (x100)
7/31/2019 Conference Ayman
13/21
7/31/2019 Conference Ayman
14/21
Histopathological examination & morphometricanalysis of Masson trichrome stained liver slides
(to assess fibrosis)
MT (x100)
7/31/2019 Conference Ayman
15/21
Immunno-histochemical examination ofliver sections to detect -SMA
x100
7/31/2019 Conference Ayman
16/21
Electron microscopy to detect newlyformed hepatocytes
x4000
7/31/2019 Conference Ayman
17/21
PCR detection of male-derived MSCs
7/31/2019 Conference Ayman
18/21
7/31/2019 Conference Ayman
19/21
BM-MSCs represent a promising toolfor the remodelling of hepatic
granulomas & fibrosis by regeneration ofhepatic tissue & decrease fibrosis incases of hepatic injury induced by
Schistosoma mansoniinfection in mice. Further studies about theimmunological mechanisms that
backgrounds the BM-MSCs remodellingrole in hepatic granulomas & fibrosis arerecommended.
7/31/2019 Conference Ayman
20/21
Extensive studies in vitro as well invivo are needed to achieve a betterunderstanding of the potential benefits
and risks of MSCs (either autologous orallogenic) and their therapeutic use inclinical cases of schistosomal hepaticinjury.
Administration of MSCs at differentintervals post infection could be studied
to determine the most appropriate timingof MSCs administration.
7/31/2019 Conference Ayman
21/21